StockData
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31

Natera, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$399.42+5.98 (+1.52%)

Close on Oct 19, 2026

Market cap
$57.23B
P/E (TTM)
–
Dividend yield
–

Natera, Inc. revenue by segment

By business segment

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Reportable Segment$752.75M$696.64M––$546.60M$501.83M––––––100.0%+37.7%
Single reportable segment––$665.50M$592.18M$546.60M$501.83M$476.06M$439.76M$413.35M$367.74M––––

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Product revenues$747.93M$693.87M$661.16M$590.20M$544.43M$500.04M$472.91M$436.13M$411.36M$364.67M$307.25M$265.22M99.4%+37.4%
Licensing and other revenues$4.82M$2.78M$4.34M$1.99M$2.17M$1.79M$3.15M$3.63M$1.99M$3.07M$3.85M$3.09M0.6%+121.9%

By region

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
United States$739.47M$685.60M$651.79M$582.37M$537.80M$492.31M$467.19M$426.27M$404.87M$359.41M$301.22M$259.87M98.2%+37.5%
Europe, Middle East, India, Africa$9.02M$6.43M–$6.01M$5.41M$6.05M–$7.72M$5.44M$5.18M–$5.26M1.2%+66.7%
Americas, excluding U.S.$2.22M$2.40M––$1.57M$1.69M––––––0.3%+41.3%
Asia Pacific and Other$2.05M$2.22M––$1.82M$1.78M––––––0.3%+12.4%
Americas, excluding U.S.––$4.57M$1.52M$1.57M$1.69M$1.54M$2.00M$1.60M$1.48M$1.26M$1.29M––
Asia Pacific and Other––$2.13M$2.28M$1.82M$1.78M$1.79M$3.76M$1.44M$1.67M$1.89M$1.89M––

From the segment and revenue-disaggregation notes of Natera's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.